PROTEOMIC-BASED BIOMARKERS FOR RISK OF PROGRESSION IN EARLY PROSTATE CANCER

$159,354FY2018Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators